humanitarian Archived signal

Human medicines European public assessment report (EPAR): Delstrigo, doravirine,lamivudine,tenofovir disoproxil, Date of authorisation: 22/11/2018, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 6, Status: Authorised

Reported by EMA What Is New Oct 19, 2026 · 14:56 UTC

Read the complete report at EMA What Is New ↗

Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

12 reports · 2 sources

EMA What Is NewHuman medicines European public assessment report (EPAR): Delstrigo, doravirine,lamivudine,tenofovir disoproxil, Date of authorisation: 22/11/2018, Revision: 15, Status: Authorised14:56 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Delstrigo, doravirine,lamivudine,tenofovir disoproxil, Date of authorisation: 22/11/2018, Revision: 15, Status: Authorised14:56 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Pifeltro, doravirine, Date of authorisation: 22/11/2018, Revision: 12, Status: Authorised14:50 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Pifeltro, doravirine, Date of authorisation: 22/11/2018, Revision: 12, Status: Authorised14:50 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Siklos, hydroxycarbamide, Date of authorisation: 29/06/2007, Revision: 32, Status: Authorised14:38 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Siklos, hydroxycarbamide, Date of authorisation: 29/06/2007, Revision: 32, Status: Authorised14:38 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Pyrukynd, mitapivat, Date of authorisation: 09/11/2022, Revision: 4, Status: Authorised14:26 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Pyrukynd, mitapivat, Date of authorisation: 09/11/2022, Revision: 4, Status: Authorised14:26 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of authorisation: 28/03/2025, Revision: 7, Status: Authorised14:20 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of authorisation: 28/03/2025, Revision: 7, Status: Authorised14:20 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Febuxostat Viatris (previously Febuxostat Mylan), febuxostat, Date of authorisation: 15/06/2017, Revision: 17, Status: Au…14:10 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Febuxostat Viatris (previously Febuxostat Mylan), febuxostat, Date of authorisation: 15/06/2017, Revision: 17, Status: Au…14:10 UTC

INCIDENT EVOLUTION

2 recorded states

Oct 19 · 15:08 UTC

Signal first indexedP2 · 99% quality · 2 sources

Oct 19 · 15:13 UTC

Headline updatedP2 · 99% quality · 2 sources

Explore this day in the archive →